Associations between the tumor necrosis factor-α gene and interleukin-10 gene polymorphisms and risk of alcoholic liver disease: A meta-analysis

Chen, 2014, Inhibition of cytochrome P4502E1 by chlormethiazole attenuated acute ethanol-induced fatty liver, Chem Biol Interact, 222 C, 18, 10.1016/j.cbi.2014.08.009 European association for the study of the liver, 2012, EASL clinical practical guidelines: management of alcoholic liver disease, J Hepatol, 57, 399, 10.1016/j.jhep.2012.04.004 Singal, 2013, Recent trends in the epidemiology of alcoholic liver disease, Clin Liver Dis, 2, 53, 10.1002/cld.168 Fan, 2013, Epidemiology of alcoholic and nonalcoholic fatty liver disease in China, J Gastroenterol Hepatol, 28, 11, 10.1111/jgh.12036 Teli, 1995, Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver, Lancet, 346, 987, 10.1016/S0140-6736(95)91685-7 Stickel, 2012, Genetic determinants of alcoholic liver disease, Gut, 61, 150, 10.1136/gutjnl-2011-301239 Stickel, 2011, Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians, Hepatology, 53, 86, 10.1002/hep.24017 Stickel, 2006, The role of genetic polymorphisms in alcoholic liver disease, Alcohol Alcohol, 41, 209, 10.1093/alcalc/agl011 Marcos, 2009, Tumor necrosis factor polymorphisms and alcoholic liver disease: a HuGE review and meta-analysis, Am J Epidemiol, 170, 948, 10.1093/aje/kwp236 Zeng, 2013, Association between CD14-159C>T polymorphisms and the risk for alcoholic liver disease: a meta-analysis, Eur J Gastroenterol Hepatol, 25, 1183 Zeng, 2013, Roles of cytochrome P4502E1 gene polymorphisms and the risks of alcoholic liver disease: a meta-analysis, PloS one, 8, e54188, 10.1371/journal.pone.0054188 Salameh, 2015, PNPLA3 gene polymorphism is associated with predisposition to and severity of alcoholic liver disease, Am J Gastroenterol, 110, 846, 10.1038/ajg.2015.137 Chamorro, 2014, Systematic review with meta-analysis: the I148M variant of patatin-like phospholipase domain-containing 3 gene (PNPLA3) is significantly associated with alcoholic liver cirrhosis, Aliment Pharmacol Ther, 40, 571, 10.1111/apt.12890 An, 2012, Cytokines in alcoholic liver disease, Arch Toxicol, 86, 1337, 10.1007/s00204-012-0814-6 Mandrekar, 2009, Signalling pathways in alcohol-induced liver inflammation, J Hepatol, 50, 1258, 10.1016/j.jhep.2009.03.007 Cederbaum, 2012, CYP2E1 sensitizes the liver to LPS- and TNF alpha-induced toxicity via elevated oxidative and nitrosative stress and activation of ASK-1 and JNK mitogen-activated kinases, Int J Hepatol, 2012, 582790, 10.1155/2012/582790 Fujimoto, 2000, Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance, Alcohol Clin Exp Res, 24, 48S, 10.1111/j.1530-0277.2000.tb00012.x Khoruts, 1991, Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients, Hepatology, 13, 267, 10.1002/hep.1840130211 Nanji, 1993, Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2, Am J Pathol, 142, 367 Yin, 1999, Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice, Gastroenterology, 117, 942, 10.1016/S0016-5085(99)70354-9 Zeng, 2014, CMZ reversed chronic ethanol-induced disturbance of PPAR-alpha possibly by suppressing oxidative stress and PGC-1alpha acetylation, and activating the MAPK and GSK3beta pathway, PloS one, 9, e98658, 10.1371/journal.pone.0098658 Jarvelainen, 2000, Kupffer cell inactivation alleviates ethanol-induced steatosis and CYP2E1 induction but not inflammatory responses in rat liver, J Hepatol, 32, 900, 10.1016/S0168-8278(00)80094-X Koop, 1997, Gadolinium chloride blocks alcohol-dependent liver toxicity in rats treated chronically with intragastric alcohol despite the induction of CYP2E1, Mol Pharmacol, 51, 944, 10.1124/mol.51.6.944 Adachi, 1994, Inactivation of Kupffer cells prevents early alcohol-induced liver injury, Hepatology, 20, 453, 10.1002/hep.1840200227 Goldman, 1996, Endogenous interleukin-10 in inflammatory disorders: regulatory roles and pharmacological modulation, Ann N Y Acad Sci, 796, 282, 10.1111/j.1749-6632.1996.tb32590.x Miller, 2011, Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines, Alcohol Clin Exp Res, 35, 787, 10.1111/j.1530-0277.2010.01399.x Szuster-Ciesielska, 2000, Serum levels of cytokines in alcoholic liver cirrhosis and pancreatitis, Arch Immunol Ther Exp (Warsz), 48, 301 McClain, 2004, Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease, Am J Physiol Gastrointest Liver Physiol, 287, G497, 10.1152/ajpgi.00171.2004 Zhong, 2006, Lipopolysaccharide-induced liver apoptosis is increased in interleukin-10 knockout mice, Biochim Biophys Acta, 1762, 468, 10.1016/j.bbadis.2005.12.012 Wilson, 1993, An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles, J Exp Med, 177, 557, 10.1084/jem.177.2.557 Gonzalez-Quintela, 2008, Serum TNF-alpha levels in relation to alcohol consumption and common TNF gene polymorphisms, Alcohol, 42, 513, 10.1016/j.alcohol.2008.04.008 Vikram, 2011, Disease markers, 31, 39, 10.1155/2011/805275 Cajado, 2011, TNF-alpha and IL-8: serum levels and gene polymorphisms (-308G>A and -251A>T) are associated with classical biomarkers and medical history in children with sickle cell anemia, Cytokine, 56, 312, 10.1016/j.cyto.2011.07.002 Bennet, 2006, Association of TNF-alpha serum levels and TNFA promoter polymorphisms with risk of myocardial infarction, Atherosclerosis, 187, 408, 10.1016/j.atherosclerosis.2005.09.022 Turner, 1997, An investigation of polymorphism in the interleukin-10 gene promoter, Eur J Immunogenet, 24, 1, 10.1111/j.1365-2370.1997.tb00001.x Shin, 2003, Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma, Hum Mol Genet, 12, 901, 10.1093/hmg/ddg104 Thelma Beatriz, 2014, Association between HTR2C gene variants and suicidal behaviour: a protocol for the systematic review and meta-analysis of genetic studies, BMJ Open, 4, e005423, 10.1136/bmjopen-2014-005423 Wu, 2015, Lack of an association between the SDF-1 rs1801157 polymorphism and coronary heart disease: a meta-analysis, Sci Rep, 5, 11803, 10.1038/srep11803 Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, T P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Stat Med, 21, 1539, 10.1002/sim.1186 Mantel, 1959, Statistical aspects of the analysis of data from retrospective studies of disease, J Natl Cancer Inst, 22, 719 Tobias, 1999, Assessing the influence of a single study in the meta-analysis estimate, Stata Tech Bull, 47, 15 Zhang, 2014, Associations between STAT3 rs744166 polymorphisms and susceptibility to ulcerative colitis and Crohn's disease: a meta-analysis, PloS one, 9 Chung, 2012, Meta-analysis of genetic polymorphisms in granulomatosis with polyangiitis (Wegener's) reveals shared susceptibility loci with rheumatoid arthritis, Arthritis Rheumatism, 64, 3463, 10.1002/art.34496 Yang, 2014, Interleukin 10 promoter haplotype is associated with alcoholic liver cirrhosis in Taiwanese patients, Kaohsiung J Med Sci, 30, 291, 10.1016/j.kjms.2014.02.016 Dutta, 2013, Genetic factors affecting susceptibility to alcoholic liver disease in an Indian population, Ann Hepatol, 12, 901, 10.1016/S1665-2681(19)31295-5 Roy, 2012, Genetic variants of TNFalpha, IL10, IL1beta, CTLA4 and TGFbeta1 modulate the indices of alcohol-induced liver injury in East Indian population, Gene, 509, 178, 10.1016/j.gene.2012.07.077 Piao, 2009, [The relationship between tumor necrosis factor alpha gene polymorphism and alcoholic liver disease in Korean and Han males of Yanbian area in China], Zhonghua Gan Zang Bing Za Zhi, 17, 632 Petrasek, 2009, Do common genetic variants in endotoxin signaling pathway contribute to predisposition to alcoholic liver cirrhosis?, Clin Chem Lab Med, 47, 398, 10.1515/CCLM.2009.112 Nguyen-Khac, 2008, The -308 TNFalpha gene polymorphism in severe acute alcoholic hepatitis: identification of a new susceptibility marker, Alcohol Clin Exp Res, 32, 822, 10.1111/j.1530-0277.2008.00629.x Gleeson, 2008, Cytokine gene polymorphisms in heavy drinkers with and without decompensated liver disease: a case-control study, Am J Gastroenterol, 103, 3039, 10.1111/j.1572-0241.2008.02150.x Auguet, 2008, A study on the TNF-alpha system in Caucasian Spanish patients with alcoholic liver disease, Drug Alcohol Depend, 92, 91, 10.1016/j.drugalcdep.2007.07.008 Richardet, 2006, Combined polymorphisms of tumour necrosis factor alpha and interleukin-10 genes in patients with alcoholic hepatitis, Eur J Gastroenterol Hepatol, 18, 673, 10.1097/00042737-200606000-00015 Pastor, 2005, -238 G>A polymorphism of tumor necrosis factor alpha gene (TNFA) is associated with alcoholic liver cirrhosis in alcoholic Spanish men, Alcohol Clin Exp Res, 29, 1928, 10.1097/01.alc.0000187595.19324.ca Martins, 2005, Are genetic polymorphisms of tumour necrosis factor alpha, interleukin-10, CD14 endotoxin receptor or manganese superoxide dismutase associated with alcoholic liver disease?, Eur J Gastroenterol Hepatol, 17, 1099, 10.1097/00042737-200510000-00014 Kim, 2004, [Genetic polymorphisms of alcohol-metabolizing enzymes and cytokines in patients with alcohol induced pancreatitis and alcoholic liver cirrhosis], Korean J Gastroenterol, 43, 355 Ladero, 2002, Single nucleotide polymorphisms and microsatellite alleles of tumor necrosis factor alpha and interleukin-10 genes and the risk of advanced chronic alcoholic liver disease, Liver, 22, 245, 10.1046/j.0106-9543.2002.01657.x Monzoni, 2001, Genetic determinants of ethanol-induced liver damage, Mol Med, 7, 255, 10.1007/BF03401845 Bathgate, 2000, Polymorphisms in tumour necrosis factor alpha, interleukin-10 and transforming growth factor beta1 genes and end-stage liver disease, Eur J Gastroenterol Hepatol, 12, 1329, 10.1097/00042737-200012120-00011 Grove, 1997, Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis, Hepatology, 26, 143, 10.1002/hep.510260119 Auguet, 2010, Polymorphisms in the interleukin-10 gene promoter and the risk of alcoholism and alcoholic liver disease in Caucasian Spaniard men, Alcohol, 44, 211, 10.1016/j.alcohol.2010.02.007 Marcos, 2008, Interleukin-10 gene polymorphism is associated with alcoholism but not with alcoholic liver disease, Alcohol Alcohol, 43, 523, 10.1093/alcalc/agn026 Newberry, 2001, Interleukin-16 promoter region potymorphisms and alcoholic liver disease, Gastroenterology, 120, A543, 10.1016/S0016-5085(08)82698-4 Grove, 2000, Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease, Gut, 46, 540, 10.1136/gut.46.4.540 Edwards-Smith, 1999, Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa, Hepatology, 30, 526, 10.1002/hep.510300207 Kebir, 2011, Association of inflammation genes with alcohol dependence/abuse: a systematic review and a meta-analysis, Eur Addict Res, 17, 146, 10.1159/000324849 Lin, 2003, Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation, N Engl J Med, 349, 2201, 10.1056/NEJMoa022060